Cover Image
close this bookInternational strategies for tropical disease treatments: Experiences with praziquantel (WHO/DAP, 1998, 113 p.)
close this folderChapter 5: The international supply of praziquantel*
View the document(introductory text...)
View the documentProducers and formulators
View the documentGlobal distribution of praziquantel
View the documentReferences

References

den Besten, H.W.A., Managing Director of IDA, Letter to M.R. Reich, March 15, 1996.

den Besten, H.W.A., Managing Director of IDA, Fax to M.R. Reich, April 24, 1996.

International Dispensary Association, IDA: Worldwide Service for the Medical Sector in Developing Countries. Amsterdam: IDA, n.d.

Kim, et al., Korean Patent No. 20,271. Patent approved on January 13, 1985.

Kim, et al., “United States Patent,” US Patent No. 4,497,952. Filed July 8, 1983. Patent approved on February 5, 1985.

King, C.H., and A.A. Mahmoud, “Drugs Five Years Later: Praziquantel,” Annals of Internal Medicine 110(4):290-296, 1989.

Scrip, “Bayer’s African Launch of Praziquantel Will Adopt ‘New Approach’,” Scrip No. 581, April 13, 1981: 15.

UNICEF, “Lifeline to Children,” New York and Copenhagen: UNICEF, 1992.

UNICEF, UNICEF Annual Report, New York: UNICEF, 1993.

UNICEF Supply Division, “Essential Drugs Price List: January-June, 1995,” Copenhagen: UNICEF, 1995.

US Pharmacopoeia, National Formulary, 22 ed., Rockville, MD: United States Pharmacopoeial Convention, Inc., 1993.

World Bank, “Brazil: Endemic Diseases Control Project, Staff Appraisal Report,” Washington, D.C.: The World Bank, 1989.

World Bank, “Standard Bidding Documents for Procurement of Pharmaceuticals and Vaccines,” Washington, D.C.: The World Bank, 1993.

World Health Organization, “Guidelines on the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce,” Adopted by the Expert Committee on Specifications for Pharmaceutical Preparations, 34th Meeting, Geneva, 29 November to 3 December 1994.